LIMS-MBnext
LIMS-MBnext is a Belgian medical analysis laboratory (MBnext Europe group) operating three sites with ~180 staff, serving prescribing physicians and specialists through classical clinical biology and a 30+ panel Preventive Investigation Biology catalog delivered via a network of ~100 collection centers in Belgium and partner sites in France.
- Company typePrivate
- Founded1994
- HeadquartersLouvain-la-neuve, Belgium
- Headcount51–100
- GTM typeB2B
- OfferingServices
What LIMS-MBnext does
LIMS-MBnext (legal entity: Laboratoire de l'Institut Médical Spécialisé SPRL, BCE 0424.567.020) is a Belgian medical analysis laboratory operating under the MBnext Europe group with three owned sites in Louvain-la-Neuve, Hornu, and Liège and approximately 180 collaborators including 8 medical biologists and pharmacist-biologists. The company runs two integrated service lines: classical clinical biology (Biologie Clinique Classique) reimbursed through INAMI, and a comprehensive Preventive Investigation Biology (BIP) portfolio of more than 30 specialized screening panels covering micronutrients, metabolic markers, genetic polymorphisms (FUT2, MTHFR, DIO2, APOE, COMT, LCT, AMY1A), microbiome metagenomics, PFAS toxicology, cardiovascular, hormonal, neurological, immune, mitochondrial, and oncology support assessments, with LC-MS/MS and targeted 16S rRNA metagenomics as core analytical platforms.
The business model combines B2B2C distribution through a network of approximately 100 collection centers across Wallonia and Brussels, partner centers in France (e.g., The Health Embassy, Cabinet Infirmier Valentin Haüy), and a home-sampling collaboration with Witte Gele Kruis in Flanders backed by DHL logistics. Revenue is generated through unit-priced clinical analyses billed to INAMI (with patient co-payments), non-reimbursed preventive BIP analyses billed directly to patients via online payment, and professional services revenue through LIMS Academy training and webinars for healthcare professionals. Prescribers access results through the CyberLab real-time tracking platform and the Espace Pro portal, while the laboratory's scientific committee of 20+ clinicians (chaired by Vincenzo Castronovo, M.D., Ph.D.) underpins a community- and education-led growth motion targeted at general practitioners, specialists, naturopaths, and nutritionists in Belgium, France, and selected EU markets.
The laboratory has Belgian agrément N°8 25607 57 998, is RGPD/GDPR-compliant with a designated DPO, and is operated alongside the Limsvet veterinary diagnostics subsidiary opened at the CBTC site in November 2024, marking the group's first move into the animal health vertical. No external funding rounds, institutional investors, or IPO activity are disclosed; ownership is concentrated within the MBnext Europe corporate umbrella.
LIMS-MBnext firmographics
Firmographics- Name
- LIMS-MBnext
- Legal name
- Laboratoire de l'Institut Médical Spécialisé SPRL
- Website
- https://lims-mbnext.eu
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- LIMS-MBnext is a Belgian medical analysis laboratory (MBnext Europe group) operating three sites with ~180 staff, serving prescribing physicians and specialists through classical clinical biology and a 30+ panel Preventive Investigation Biology catalog delivered via a network of ~100 collection centers in Belgium and partner sites in France.
- Ownership category
- akta.pro rank
LIMS-MBnext industry classification
Industry- Product category
- Medical Laboratory Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Laboratory LIS (Core Lab/Hospital Lab) (HLACAMAA)
- akta.pro secondary industries
- Public Health & Reference Lab LIMS (HLACAMAF), Molecular & Genomic LIMS (NGS/Bioinformatics Lab Ops) (HLACAMAC), Microbiology LIS/LIMS (HLACAMAD), Laboratory Information Management Systems (LIMS) (HLAGAJAA)
Keywords
Where LIMS-MBnext is headquartered
LocationHeadquarters
- HQ city
- Louvain-la-neuve
- HQ country
- Belgium
- HQ region
- Europe
Offices3 records
Markets served
LIMS-MBnext business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Clinical Biology Analyses: Standard clinical biology analyses reimbursed by INAMI (Belgian national health insurance). The laboratory bills INAMI directly for covered analyses, with patients responsible for co-payments (ticket modérateur).
- Preventive Biology Analyses: Non-INAMI reimbursed preventive and functional medicine analyses billed directly to patients. These include specialized BIP profiles, genetic polymorphism tests, microbiome analyses, and PFAS testing. Patients receive invoices and can pay online.
- Professional Services and Training: LIMS Academy provides training and webinars to healthcare professionals, generating revenue through educational programs. Dedicated services for health professionals include interpretation tools, documentation, and videotheque access.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | PFAS Analysis - Single test at 68€ |
| Unit Pricing | Pay-as-you-go | Preventive Investigation Biology (BIP) Profiles |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
LIMS-MBnext product offering
Product offeringCore offering
LIMS-MBnext is a Belgian medical analysis laboratory operating three sites (Louvain-la-Neuve, Hornu, Liège) that delivers clinical biology analyses reimbursed by INAMI and a catalogue of more than 30 preventive investigation biology (BIP) panels — including intestinal, cardiovascular, hormonal, mitochondrial, neuropsychological, immune, genetic polymorphism and environmental toxicology (PFAS) assessments — to healthcare professionals who prescribe them for their patients. The laboratory supports prescribers through dedicated professional portals (CyberLab, Espace Pro), continuous education (LIMS Academy), home sampling services, and a network of partner collection centers across Belgium and France, complemented by a veterinary diagnostics subsidiary (Limsvet).
Product overview
LIMS-MBnext is a Belgian medical analyses laboratory (approx. 180 staff, 8 medical biologists/pharmacists) operating three sites in Louvain-la-Neuve, Hornu, and Liège. The company offers two core service lines: (1) Biologie Clinique Classique covering routine clinical biology analyses, and (2) Biologie d'Investigation Préventive (BIP) — a comprehensive portfolio of over 30 specialized preventive health screening panels. The BIP portfolio includes Initial Screening panels (BIPI Intestin, BIPI Candidose, BIPI Stress, BIPI Cardio, BIP Armure Immunitaire 1.0) and Classic Preventive panels covering intestinal health (Microbiote, Dysbiose, Femibiote), metabolic and cardiovascular function (Cardio 2.0, Stéatose, Fatigue 40+, Métabolisme), hormonal and reproductive health (Fertilité, Hypothyroïdie, Métabolisme des Œstrogènes), neurological and psychological assessment (Brain, Anxiété-Dépression-Burnout, Neurotransmetteurs), genetic polymorphisms (FUT2, MTHFR, DIO2, APOE, COMT, LCT, AMY1A), immune function (Typage Lymphocytaire, Armure Immunitaire 2.1), mitochondrial and oxidative stress support (Mitochondrie, Stress Oxydatif), cancer treatment accompaniment, wound healing, and environmental toxicology (PFAS). Supporting services include CyberLab real-time patient tracking, Espace Pro professional portal, LIMS Academy training, home sampling, multilingual documentation (FR/EN/NL), and logistics for international clients. A veterinary subsidiary (Limsvet) also operates from the Louvain-la-Neuve site.
Differentiator
Problem solved
Functional benefit
Brands
- Cyberlab: Real-time patient file tracking platform for healthcare professionals
- LIMS Academy
- Limsvet
- BIP (Bilans d'Investigation Préventive)
- Scientific Committee
Quantifiable outcome
- PFAS analysis with detection limit below 0.1 µg/l for 6 PFAS compounds
- +2 more outcomes
Companies that use LIMS-MBnext
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
LIMS-MBnext technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
LIMS-MBnext partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- GLAB (Maroc)coreInternational collaboration with Morocco, involving scientific exchange and laboratory services development in preventive biology.
- AlamedacorePartner in scientific collaboration and preventive medicine development.
- SympminorSymposium and event partnership for healthcare professional education.
- Witte Gele KruiscoreCollaboration with Witte Gele Kruis nurses for home blood sampling in Flanders (Eastern Flanders, Flemish Brabant, Antwerp, Limburg). Nurses collect samples, DHL transports to LIMS laboratory.
- DHLcoreTransport partner for sample logistics in Flanders, collecting samples from Witte Gele Kruis locations and delivering to the laboratory.
- ChronopostminorTransport carrier for sample shipments from non-Belgian patients, particularly in France.
- Limsvet (Veterinary Analysis Laboratory)minorVeterinary analysis laboratory operated by MBnext Europe group, located at CBTC site in Louvain-la-Neuve.
- NutriHealth AcademyminorTraining and education partnership for healthcare professionals in nutrition and preventive medicine.
- DFM FormationsminorFormation and education partner in functional medicine.
- SynamiefminorEvent partner for healthcare professional congress scheduled for June 12, 2026 in Paris.
Scale indicators5 records
Recent moves8 records
Expansion highlights7 records
LIMS-MBnext competitors and assessment
Company assessmentDirect peers
- Laboratoire Bioffice: Belgian preventive and functional medicine laboratory offering comprehensive preventive screening panels to healthcare professionals. Highly comparable in preventive biology catalog, prescriber-focused GTM, and Belgian market overlap.
- Limsvet: Veterinary analysis laboratory operating at the same CBTC site in Louvain-la-Neuve under the MBnext Europe group. Comparable as a sister entity with shared infrastructure and similar analytical platform applied to animal diagnostics.
- Inovie: French private medical biology laboratory group operating regional labs and collection centers. Comparable as a clinical lab serving physician prescribers via collection-center networks in neighboring France.
- Eurofins Genoma Group: European specialty genetics and molecular diagnostics laboratory offering genetic testing, microbiome and molecular panels. Comparable as a specialty lab offering genetic polymorphism, microbiome, and advanced molecular testing to physicians and clinics.
- Biogroup: France- and Belgium-based clinical laboratory network delivering routine and specialty testing through collection centers and B2B prescriber relationships. Highly comparable in business model, prescribers channel, and geographic overlap in northern France and Belgium.
- Medivere Diagnostik: German preventive diagnostics laboratory offering specialty panels in micronutrients, hormones, stool and environmental medicine. Comparable as a preventive-medicine-focused lab serving naturopaths and integrative physicians with comparable BIP-style panel offerings.
- GanzImmun Diagnostics: German specialty laboratory focused on preventive medicine, immunology and functional diagnostics for practitioners. Comparable as a preventive-medicine specialist lab with a physician-prescriber model and comprehensive specialty panels.
Broad incumbents
- Cerba Healthcare: European reference laboratory group providing specialized and routine clinical diagnostics to physicians, hospitals and industry. Comparable as a European reference lab with overlapping specialty testing capabilities and physician-focused GTM.
- Synlab: Pan-European medical diagnostics leader offering routine and specialty clinical laboratory services across multiple countries. Comparable as a large-scale clinical lab competitor with broader geographic reach but less specialization in preventive/functional medicine panels.
- Unilabs: Major European diagnostics provider offering clinical laboratory and imaging services. Comparable as a multi-country clinical lab competitor serving physician prescribers across routine and specialty testing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks4 records
Key highlights7 records
Customer concentration
LIMS-MBnext social profiles
Digital presenceLIMS-MBnext compliance and trust
Trust signalCompliance3 records
LIMS-MBnext financial estimates
Financial estimateRevenue estimate
Valuation estimate
LIMS-MBnext leadership team
Management profileNumber of profiles
Profiles5 records
LIMS-MBnext subsidiaries and ownership
Company hierarchySubsidiaries2 records
LIMS-MBnext funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LIMS-MBnext M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LIMS-MBnext
What does LIMS-MBnext do?
LIMS-MBnext is a Belgian medical analysis laboratory operating three sites (Louvain-la-Neuve, Hornu, Liège) that delivers clinical biology analyses reimbursed by INAMI and a catalogue of more than 30 preventive investigation biology (BIP) panels — including intestinal, cardiovascular, hormonal, mitochondrial, neuropsychological, immune, genetic polymorphism and environmental toxicology (PFAS) assessments — to healthcare professionals who prescribe them for their patients. The laboratory supports prescribers through dedicated professional portals (CyberLab, Espace Pro), continuous education (LIMS Academy), home sampling services, and a network of partner collection centers across Belgium and France, complemented by a veterinary diagnostics subsidiary (Limsvet).
Is LIMS-MBnext a public or private company?
LIMS-MBnext is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LIMS-MBnext founded?
LIMS-MBnext was founded in 1994. It employs 51 to 100 people.
Where is LIMS-MBnext based?
LIMS-MBnext is headquartered in Louvain-la-neuve, Belgium, in the Europe region.
How does LIMS-MBnext make money?
Three revenue lines are on record. Clinical Biology Analyses are the primary driver. The others are preventive Biology Analyses and professional Services and Training.
Who are LIMS-MBnext's main competitors?
Direct peers on record are Laboratoire Bioffice, Limsvet, Inovie, Eurofins Genoma Group, Biogroup, Medivere Diagnostik and GanzImmun Diagnostics. Broad incumbents are Cerba Healthcare, Synlab and Unilabs.
Does LIMS-MBnext have an API?
No public API is recorded for LIMS-MBnext.
What industry is LIMS-MBnext in?
LIMS-MBnext's product category is Medical Laboratory Services. Its primary akta.pro industry code is HLACAMAA, Clinical Laboratory LIS (Core Lab/Hospital Lab), with a secondary code of HLACAMAF, Public Health & Reference Lab LIMS. Its NAICS code is 6215 and its SIC code is 8071.